Algorae advances Umedica medicine towards Australian approval

• Exclusive Australian importer, distributor and commercial partner rights across eight Umedica-branded molecules
• Binding licence and supply agreement covers a separate product to be sold under Algorae’s own brand
• Product dossier submitted to the TGA, but approval has not yet been granted
• Umedica will supply the product and license its dossier and know-how